Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 05 03 2020
revised: 08 05 2020
pubmed: 7 8 2020
medline: 28 4 2021
entrez: 7 8 2020
Statut: ppublish

Résumé

How does exposure to a testosterone rich environment affect the function and gene expression of human fallopian tube epithelium (hFTE)? Elevated testosterone level alters several gene transcripts that regulate cilia expression and negatively impacts the rate of cilia beating. The presence of estrogen in the follicular phase of the menstrual cycle increases the human fallopian tube ciliary beating frequency. The luteal phase, triggered by ovulation and increasing progesterone, is marked by a decrease in ciliary beating. Women with polycystic ovarian syndrome (PCOS) may have twice the serum level of testosterone than ovulatory women. To date, the effect of elevated androgens on the function of the human fallopian tube is not well-understood. We chose to examine the impact of elevated testosterone on hFTE. A prospective basic science study of human fallopian tube specimens from reproductive-aged women undergoing benign gynecologic surgery was performed. Fallopian tube removal at a large US academic center was collected and provided to us to continue with epithelium isolation and culturing. A total of 12 patients were analyzed in the study. Fallopian tube epithelium was isolated and exposed to two different conditions: normal with low testosterone concentration of 0.8 nM and PCOS-like, with high testosterone concentration of 2 nM. The study was conducted in both static and dynamic conditions in microfluidic devices for a total of 14 days, after which the tissue was collected for processing including RNA extraction, quantitative PCR and immunohistochemistry. After the first 7 days of each experiment, a sample of tissue from each condition was imaged to quantify cilia beating frequency. hFTE exposed to the 2 nM testosterone displayed slower cilia beating, inhibited estrogen signaling and decreased expression of the ciliary marker FOXJ1 when compared to stimulation with 0.8 nM testosterone. N/A. The in vivo response to elevated testosterone may differ from in vitro studies. RNA amount was limited from tissue cultured in the microfluidic devices as compared to static culture. Understanding elevated testosterone in tubal function may explain an additional contribution to subfertility in women with PCOS and other hyper-androgen disorders, aside from oligo-ovulation. Furthermore, this adds to the body of literature of fallopian tube function using a microfluidic device. NIH grants: UH3 ES029073 and R01 CA240301. There are no competing interests.

Identifiants

pubmed: 32756960
pii: 5881295
doi: 10.1093/humrep/deaa157
pmc: PMC7550267
doi:

Substances chimiques

Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2086-2096

Subventions

Organisme : NCI NIH HHS
ID : P30 CA060553
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240301
Pays : United States
Organisme : NIEHS NIH HHS
ID : UG3 ES029073
Pays : United States
Organisme : NIEHS NIH HHS
ID : UH3 ES029073
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Science. 1976 Mar 12;191(4231):1052-3
pubmed: 1251215
Int J Fertil Steril. 2015 Apr-Jun;9(1):55-64
pubmed: 25918593
Reprod Biol Endocrinol. 2014 Jul 06;12:60
pubmed: 24997727
Nat Genet. 2008 Dec;40(12):1445-53
pubmed: 19011630
Cells Tissues Organs. 2000;166(2):165-79
pubmed: 10729726
Endocr Rev. 1984 Fall;5(4):525-51
pubmed: 6094174
Acta Obstet Gynecol Scand. 1983;62(6):625-7
pubmed: 6608204
Ital J Anat Embryol. 2005;110(2 Suppl 1):195-203
pubmed: 16101039
Mol Hum Reprod. 2016 Nov;22(11):756-767
pubmed: 27542947
Am J Respir Cell Mol Biol. 2008 Jul;39(1):45-52
pubmed: 18276795
Biol Reprod. 1989 Jun;40(6):1131-6
pubmed: 2775809
Mol Hum Reprod. 2013 Dec;19(12):828-37
pubmed: 24026057
Nat Rev Mol Cell Biol. 2011 Apr;12(4):222-34
pubmed: 21427764
Biol Reprod. 1997 Jun;56(6):1415-23
pubmed: 9166693
Am J Obstet Gynecol. 2013 Aug;209(2):139.e1-9
pubmed: 23659986
Biol Reprod. 1996 Nov;55(5):996-1002
pubmed: 8902209
Hum Reprod. 2006 Jan;21(1):52-6
pubmed: 16172146
Nat Rev Mol Cell Biol. 2002 Nov;3(11):813-25
pubmed: 12415299
J Clin Endocrinol Metab. 2009 Dec;94(12):5146-54
pubmed: 19864448
Fertil Steril. 2000 Apr;73(4):724-9
pubmed: 10731532
Steroids. 2008 May;73(5):473-87
pubmed: 18321551
Annu Rev Cell Dev Biol. 2003;19:423-43
pubmed: 14570576
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
Acta Obstet Gynecol Scand. 1957;36(1):22-8
pubmed: 13424207
Sex Transm Dis. 1999 Mar;26(3):160-5
pubmed: 10100774
Front Pharmacol. 2012 Nov 06;3:185
pubmed: 23133418
J Infect Dis. 1981 Mar;143(3):413-22
pubmed: 6785363
J Cell Biol. 1992 Dec;119(6):1605-11
pubmed: 1281816
Hum Reprod Update. 1997 Nov-Dec;3(6):541-52
pubmed: 9584944
Reprod Biol Endocrinol. 2017 Feb 10;15(1):12
pubmed: 28183310
Fertil Steril. 2010 Sep;94(4):1399-1404
pubmed: 19591989
Cancer Res. 2017 Jul 15;77(14):3951-3960
pubmed: 28381542
Am J Anat. 1979 Dec;156(4):505-21
pubmed: 525625
Carcinogenesis. 2020 Jul 10;41(5):646-655
pubmed: 31271204
Br J Obstet Gynaecol. 1977 Mar;84(3):216-8
pubmed: 843498
Biol Reprod. 2003 May;68(5):1870-6
pubmed: 12606391
Mol Reprod Dev. 2020 Jan;87(1):30-44
pubmed: 31705839
Hum Reprod. 1998 Nov;13(11):3121-7
pubmed: 9853868
Hum Reprod Update. 2006 Jul-Aug;12(4):363-72
pubmed: 16565155
Biol Reprod. 1989 Jun;40(6):1299-310
pubmed: 2550088
Fertil Steril. 1978 Jan;29(1):72-4
pubmed: 304420
Endocr Rev. 2013 Feb;34(1):130-62
pubmed: 23303565
Infect Immun. 1986 Feb;51(2):425-30
pubmed: 2417954
Hum Reprod. 2015 Dec;30(12):2871-80
pubmed: 26373788
Br J Obstet Gynaecol. 1977 Mar;84(3):219-21
pubmed: 843499
Eur Respir J. 2017 Nov 9;50(5):
pubmed: 29122913
Chest. 1989 Mar;95(3):578-81
pubmed: 2784093
Nat Commun. 2017 Mar 28;8:14584
pubmed: 28350383
Am J Epidemiol. 2003 Feb 1;157(3):185-94
pubmed: 12543617
Oncogene. 2018 Apr;37(15):1976-1990
pubmed: 29367766
Hum Reprod. 1997 Jan;12(1):55-8
pubmed: 9043902
Fertil Steril. 1986 Sep;46(3):412-6
pubmed: 3488922
Facts Views Vis Obgyn. 2013;5(4):292-7
pubmed: 24753957
J Gen Microbiol. 1990 Jun;136(6):1109-15
pubmed: 2384745
Hum Reprod. 2003 Nov;18(11):2264-9
pubmed: 14585871
J Sex Med. 2008 Apr;5(4):854-863
pubmed: 18371044

Auteurs

Tia Jackson-Bey (T)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60607, USA.

José Colina (J)

Department of Pharmaceutical Biosciences, University of Illinois at Chicago, Chicago, IL 60607, USA.

Brett C Isenberg (BC)

Biological Microsystem Group, Bioengineering Division, Charles Stark Draper Laboratory, Cambridge, MA 02139, USA.

Jonathan Coppeta (J)

Biological Microsystem Group, Bioengineering Division, Charles Stark Draper Laboratory, Cambridge, MA 02139, USA.

Margrit Urbanek (M)

Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

J Julie Kim (JJ)

Division of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Teresa K Woodruff (TK)

Division of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Joanna E Burdette (JE)

Department of Pharmaceutical Biosciences, University of Illinois at Chicago, Chicago, IL 60607, USA.

Angela Russo (A)

Department of Pharmaceutical Biosciences, University of Illinois at Chicago, Chicago, IL 60607, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH